{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T20:58:36Z","timestamp":1794344316796,"version":"4.9.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Selective glomerular hypofiltration syndrome (SGHS), formerly shrunken pore syndrome, an emerging marker of glomerular dysfunction, is associated with worsened prognosis in cardiovascular disease, but its role in kidney failure remains underexplored. Osteopontin (OPN) is associated with worsening kidney function and prognosis in chronic kidney disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>To explore if increased levels of OPN and SGHS are associated with hospitalization for kidney failure in patients with acute heart failure (HF).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>OPN was analyzed in 315 hospitalized HF patients using a proximity extension assay. SGHS was defined as cystatin C-based estimated GFR (eGFR)\u2009&lt;\u200960% of the creatinine-based eGFR. Clinical outcomes were retrieved from regional registries (ICD-10 N17-N19). Multivariable logistic and Cox regression models adjusted for known risk factors were used for associations between OPN and SGHS and their association with hospitalization for kidney failure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The mean age was 74 years, 33% were female and 15% presented with SGHS. Patients with SGHS had higher BMI, OPN- and cystatin C levels and higher mean eGFR. During the median follow-up period of 28 months, 46 patients were hospitalized for kidney failure. Increased OPN-levels were associated with prevalent SGHS (odds ratio 2.50, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and higher risk of hospitalization for acute kidney failure (hazard ratio (HR) 4.66, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) as did prevalent SGHS (HR 4.82, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In HF patients, OPN was associated with a higher prevalence of SGHS and both OPN and SGHS were associated with higher risk of hospitalization for kidney failure. Our results suggest that OPN and SGHS can identify HF patients at high risk of kidney function decline.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12882-025-04481-w","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T13:16:39Z","timestamp":1759756599000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of Osteopontin and selective glomerular hypofiltration syndrome with hospitalization for kidney failure in acute heart failure patients"],"prefix":"10.1186","volume":"26","author":[{"given":"Marcus Andreas","family":"Ohlsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Molvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes Holm","family":"Isholth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Grubb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Christensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amra","family":"Jujic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Magnusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"issue":"4","key":"4481_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3109\/00365513.2015.1025427","volume":"75","author":"A Grubb","year":"2015","unstructured":"Grubb A, Lindstr\u00f6m V, Jonsson M, B\u00e4ck SE, \u00c5hlund T, Rippe B, et al. Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: \u2018Shrunken pore syndrome\u2019. Scand J Clin Lab Invest. 2015;75(4):333\u201340.","journal-title":"Scand J Clin Lab Invest"},{"issue":"5","key":"4481_CR2","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1080\/00365513.2020.1759139","volume":"80","author":"A \u00c5kesson","year":"2020","unstructured":"\u00c5kesson A, Lindstr\u00f6m V, Nyman U, Jonsson M, Abrahamson M, Christensson A, et al. Shrunken pore syndrome and mortality: a cohort study of patients with measured GFR and known comorbidities. Scand J Clin Lab Invest. 2020;80(5):412\u201322.","journal-title":"Scand J Clin Lab Invest"},{"issue":"3","key":"4481_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/joim.13589","volume":"293","author":"L Malmgren","year":"2023","unstructured":"Malmgren L, \u00d6berg C, den Bakker E, Leion F, Si\u00f3dmiak J, \u00c5kesson A, et al. The complexity of kidney disease and diagnosing it - cystatin C, selective glomerular Hypofiltration syndromes and proteome regulation. J Intern Med. 2023;293(3):293\u2013308.","journal-title":"J Intern Med"},{"issue":"1","key":"4481_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3109\/00365513.2015.1099724","volume":"76","author":"A Dardashti","year":"2016","unstructured":"Dardashti A, Nozohoor S, Grubb A, Bjursten H. Shrunken pore syndrome is associated with a Sharp rise in mortality in patients undergoing elective coronary artery bypass grafting. Scand J Clin Lab Invest. 2016;76(1):74\u201381.","journal-title":"Scand J Clin Lab Invest"},{"key":"4481_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.trsl.2015.11.001","volume":"169","author":"Purde","year":"2016","unstructured":"Purde MT, Nock S, Risch L, Medina Escobar P, Grebhardt C, Nydegger UE, et al. The Cystatin C\/creatinine ratio, a marker of glomerular filtration quality: associated factors, reference intervals, and prediction of morbidity and mortality in healthy seniors. Transl Res. 2016;169:80\u201390. e1-2.","journal-title":"Transl Res"},{"issue":"4","key":"4481_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3109\/00365513.2016.1149882","volume":"76","author":"MT Purde","year":"2016","unstructured":"Purde MT, Nock S, Risch L, Medina Escobar P, Grebhardt C, Nydegger UE, et al. Ratio of Cystatin C and creatinine-based estimates of the glomerular filtration rate predicts mortality in healthy seniors independent of kidney function. Scand J Clin Lab Invest. 2016;76(4):341\u20133.","journal-title":"Scand J Clin Lab Invest"},{"issue":"7","key":"4481_CR7","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1080\/00365513.2016.1223338","volume":"76","author":"A Christensson","year":"2016","unstructured":"Christensson A, Grubb A, Molvin J, Holm H, Gransbo K, Tasevska-Dinevska G, et al. The shrunken pore syndrome is associated with declined right ventricular systolic function in a heart failure population - the HARVEST study. Scand J Clin Lab Invest. 2016;76(7):568\u201374.","journal-title":"Scand J Clin Lab Invest"},{"issue":"5","key":"4481_CR8","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1002\/ehf2.13485","volume":"8","author":"L Xhakollari","year":"2021","unstructured":"Xhakollari L, Grubb A, Jujic A, Bachus E, Nilsson PM, Leosdottir M, et al. The shrunken pore syndrome is associated with poor prognosis and lower quality of life in heart failure patients: the HARVEST-Malm\u00f6 study. ESC Heart Fail. 2021;8(5):3577\u201386.","journal-title":"ESC Heart Fail"},{"issue":"5","key":"4481_CR9","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1080\/00365513.2020.1759139","volume":"80","author":"A \u00c5kesson","year":"2020","unstructured":"\u00c5kesson A, Lindstr\u00f6m V, Nyman U, Jonsson M, Abrahamson M, Christensson A, et al. Shrunken pore syndrome and mortality: a cohort study of patients with measured GFR and known comorbidities. Scand J Clin Lab Investig. 2020;80(5):412\u201322.","journal-title":"Scand J Clin Lab Investig"},{"issue":"9","key":"4481_CR10","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.2215\/CJN.0000000000000217","volume":"18","author":"DK Farrington","year":"2023","unstructured":"Farrington DK, Surapaneni A, Matsushita K, Seegmiller JC, Coresh J, Grams ME. Discrepancies between Cystatin C-Based and Creatinine-Based eGFR. Clin J Am Soc Nephrol. 2023;18(9):1143\u201352.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"13","key":"4481_CR11","doi-asserted-by":"publisher","first-page":"e14939","DOI":"10.14814\/phy2.14939","volume":"9","author":"CM \u00d6berg","year":"2021","unstructured":"\u00d6berg CM, Lindstr\u00f6m M, Grubb A, Christensson A. Potential relationship between eGFR(cystatin C) \/eGFR(creatinine) -ratio and glomerular basement membrane thickness in diabetic kidney disease. Physiol Rep. 2021;9(13):e14939.","journal-title":"Physiol Rep"},{"issue":"4","key":"4481_CR12","doi-asserted-by":"publisher","first-page":"e2000089","DOI":"10.1002\/prca.202000089","volume":"15","author":"L Xhakollari","year":"2021","unstructured":"Xhakollari L, Jujic A, Molvin J, Nilsson P, Holm H, Bachus E, et al. Proteins linked to atherosclerosis and cell proliferation are associated with the shrunken pore syndrome in heart failure patients: Shrunken pore syndrome and proteomic associations. Proteom Clin Appl. 2021;15(4):e2000089.","journal-title":"Proteom Clin Appl"},{"issue":"9","key":"4481_CR13","first-page":"1208","volume":"35","author":"H Yogasundaram","year":"2019","unstructured":"Yogasundaram H, Chappell MC, Braam B, Oudit GY. Cardiorenal syndrome and heart failure-challenges and opportunities. Can J Cardiol. 2019;35(9):1208\u201319.","journal-title":"Can J Cardiol"},{"key":"4481_CR14","doi-asserted-by":"crossref","unstructured":"Pliquett RU. Cardiorenal syndrome: an updated classification based on clinical hallmarks. J Clin Med. 2022 May 11;11(10).","DOI":"10.3390\/jcm11102896"},{"issue":"2","key":"4481_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3109\/00365511003642535","volume":"70","author":"A Grubb","year":"2010","unstructured":"Grubb A. Non-invasive estimation of glomerular filtration rate (GFR). The Lund model: Simultaneous use of cystatin C- and creatinine-based GFR-prediction equations, clinical data and an internal quality check. Scand J Clin Lab Invest. 2010;70(2):65\u201370.","journal-title":"Scand J Clin Lab Invest"},{"key":"4481_CR16","doi-asserted-by":"publisher","first-page":"960059","DOI":"10.3389\/fphys.2022.960059","volume":"13","author":"C Zou","year":"2022","unstructured":"Zou C, Wang C, Lu L. Advances in the study of subclinical AKI biomarkers. Front Physiol. 2022;13:960059.","journal-title":"Front Physiol"},{"issue":"3","key":"4481_CR17","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1681\/ASN.2008070669","volume":"20","author":"SS Waikar","year":"2009","unstructured":"Waikar SS, Bonventre JV. Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol. 2009;20(3):672\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"4481_CR18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s13054-023-04747-5","volume":"27","author":"L-C Lin","year":"2023","unstructured":"Lin L-C, Chuan M-H, Liu J-H, Liao H-W, Ng LL, Magnusson M, et al. Proenkephalin as a biomarker correlates with acute kidney injury: a systematic review with meta-analysis and trial sequential analysis. Crit Care. 2023;27(1):481.","journal-title":"Crit Care"},{"issue":"2","key":"4481_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00011-018-1200-5","volume":"68","author":"B Kaleta","year":"2019","unstructured":"Kaleta B. The role of osteopontin in kidney diseases. Inflamm Res. 2019;68(2):93\u2013102.","journal-title":"Inflamm Res"},{"issue":"6","key":"4481_CR20","first-page":"1430","volume":"38","author":"I Steinbrenner","year":"2023","unstructured":"Steinbrenner I, Sekula P, Kotsis F, von Cube M, Cheng Y, Nadal J, et al. Association of osteopontin with kidney function and kidney failure in chronic kidney disease patients: the GCKD study. Nephrology, Dialysis, Transplantation: official publication of the European Dialysis and Transplant Association. Eur Ren Association. 2023;38(6):1430\u20138.","journal-title":"Eur Ren Association"},{"issue":"7","key":"4481_CR21","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/ki.2009.515","volume":"77","author":"JG Heuer","year":"2010","unstructured":"Heuer JG, Breyer MD. Osteopontin in diabetic nephropathy: signpost or road? Kidney Int. 2010;77(7):565\u20136.","journal-title":"Kidney Int"},{"issue":"3","key":"4481_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3109\/00365513.2011.557086","volume":"71","author":"J Bj\u00f6rk","year":"2011","unstructured":"Bj\u00f6rk J, Grubb A, Sterner G, Nyman U. Revised equations for estimating glomerular filtration rate based on the Lund-Malm\u00f6 study cohort. Scand J Clin Lab Invest. 2011;71(3):232\u20139.","journal-title":"Scand J Clin Lab Invest"},{"issue":"7","key":"4481_CR23","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1373\/clinchem.2013.220707","volume":"60","author":"A Grubb","year":"2014","unstructured":"Grubb A, Horio M, Hansson LO, Bj\u00f6rk J, Nyman U, Flodin M, et al. Generation of a new cystatin C-based estimating equation for glomerular filtration rate by use of 7 assays standardized to the international calibrator. Clin Chem. 2014;60(7):974\u201386.","journal-title":"Clin Chem"},{"key":"4481_CR24","doi-asserted-by":"publisher","first-page":"2177991","DOI":"10.1155\/2022\/2177991","volume":"2022","author":"Z Wu","year":"2022","unstructured":"Wu Z, Wang L, Li Y, Yao Y, Zeng R. Shrunken pore syndrome is associated with renal function decline in female patients with kidney diseases. Biomed Res Int. 2022;2022:2177991.","journal-title":"Biomed Res Int"},{"issue":"1","key":"4481_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00365513.2021.1989714","volume":"82","author":"C Zhou","year":"2022","unstructured":"Zhou C, Chen Y, He X, Xue D. The value of Cystatin C in predicting perioperative and long-term prognosis of renal transplantation. Scand J Clin Lab Invest. 2022;82(1):1\u20135.","journal-title":"Scand J Clin Lab Invest"},{"key":"4481_CR26","doi-asserted-by":"crossref","unstructured":"Curtis M, Swan L, Fox R, Warters A, O\u2019Sullivan M. Associations between body mass index and probable sarcopenia in community-dwelling older adults. Nutrients. 2023 Mar 15;15(6).","DOI":"10.3390\/nu15061505"},{"issue":"5","key":"4481_CR27","doi-asserted-by":"publisher","first-page":"e020745","DOI":"10.1161\/JAHA.121.020745","volume":"11","author":"M West","year":"2022","unstructured":"West M, Kirby A, Stewart RA, Blankenberg S, Sullivan D, White HD, et al. Circulating Cystatin C is an independent risk marker for cardiovascular Outcomes, development of renal Impairment, and long-term mortality in patients with stable coronary heart disease: the LIPID study. J Am Heart Association. 2022;11(5):e020745.","journal-title":"J Am Heart Association"},{"key":"4481_CR28","doi-asserted-by":"crossref","unstructured":"Chen S, Tang Y, Zhou X. Cystatin C for predicting all-cause mortality and rehospitalization in patients with heart failure: a meta-analysis. Biosci Rep. 2019 Feb 28;39(2):BSR20182320.","DOI":"10.1042\/BSR20181761"},{"issue":"1","key":"4481_CR29","doi-asserted-by":"publisher","first-page":"6340","DOI":"10.1038\/s41467-023-41642-7","volume":"14","author":"RF Dubin","year":"2023","unstructured":"Dubin RF, Deo R, Ren Y, Wang J, Zheng Z, Shou H, et al. Proteomics of CKD progression in the chronic renal insufficiency cohort. Nat Commun. 2023;14(1):6340.","journal-title":"Nat Commun"},{"issue":"7","key":"4481_CR30","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/ki.2009.518","volume":"77","author":"SB Nicholas","year":"2010","unstructured":"Nicholas SB, Liu J, Kim J, Ren Y, Collins AR, Nguyen L, et al. Critical role for osteopontin in diabetic nephropathy. Kidney Int. 2010;77(7):588\u2013600.","journal-title":"Kidney Int"},{"issue":"8","key":"4481_CR31","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.3390\/cimb44080245","volume":"44","author":"A Mamazhakypov","year":"2022","unstructured":"Mamazhakypov A, Sartmyrzaeva M, Sarybaev AS, Schermuly R, Sydykov A. Clinical and molecular implications of osteopontin in heart failure. Curr Issues Mol Biol. 2022;44(8):3573\u201397.","journal-title":"Curr Issues Mol Biol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04481-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04481-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04481-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T13:16:41Z","timestamp":1759756601000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04481-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4481"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04481-w","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local Ethical Review Board at Lund University, Sweden. Written informed consent was obtained from all participants. The study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"550"}}